← Leaderboards
Michel Baudry
University Of Southern California
$7,748,180
Attributed
$7,942,870
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $818.1K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,942,870 · 8
By mechanism
R01$5,301,448 · 3
P01$1,555,245 · 2
R21$829,539 · 2
R41$256,638 · 1
Top collaborators
- Yun Luo2 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Steven Scott Schreiber$998,166
- John C Wood$11,655,933
Others in their field
Top investigators on “Slice”
- Ed Lein · Allen Institute$60,364,977
- Hongkui Zeng · Allen Institute$43,701,398
- Steven Andrew McCarroll · Broad Institute, Inc.$27,107,011
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
- Pamela Susan Douglas · Duke University$22,678,087
- Jeff W Lichtman · Washington University$22,353,357
Research focus
SliceHippocampus (Brain)BrainLearningNeuronsSynaptic PlasticityLong-Term PotentiationLinkSynapsesIn VitroSiteMemoryMediatingImpairmentIn VivoProgramsGlycineMolecularComplexPathway InteractionsVertebral ColumnCalciumPlayDesign
Grant awards (29)
Roles of UBE3A-mediated p18 regulation in synaptogenesis and synaptic plasticity$308,438
R01 · FY2022 · NS · contact PI
Roles of UBE3A-mediated p18 regulation in synaptogenesis and synaptic plasticity$308,438
R01 · FY2021 · NS · contact PI
Roles of UBE3A-mediated p18 regulation in synaptogenesis and synaptic plasticity$308,438
R01 · FY2020 · NS · contact PI
Roles of UBE3A-mediated p18 regulation in synaptogenesis and synaptic plasticity$308,438
R01 · FY2019 · NS · contact PI
Roles of UBE3A-mediated p18 regulation in synaptogenesis and synaptic plasticity$308,438
R01 · FY2018 · NS · contact PI
Development of a selective calpain-2 inhibitor for treating learning impairment in AS$178,750
R21 · FY2016 · NS · contact PI
Development of a selective calpain-2 inhibitor for treating learning impairment in AS$210,630
R21 · FY2015 · NS · contact PI
Simulation of learning: models and biological validation$547,170
R01 · FY2012 · NS · contact PI
Simulation of learning: models and biological validation$553,012
R01 · FY2011 · NS · contact PI
Simulation of learning: models and biological validation$573,211
R01 · FY2010 · NS · contact PI
Potential use of a decoy peptide for hypoxia/ischemia treatment$194,659
R21 · FY2010 · NS · contact PI
Simulation of learning: models and biological validation$561,095
R01 · FY2009 · NS · contact PI
Potential use of a decoy peptide for hypoxia/ischemia treatment$245,500
R21 · FY2009 · NS · contact PI
Simulation of learning: models and biological validation$11,500
R01 · FY2009 · NS · contact PI
Calpain inhibitors in models of Parkinson's disease$285,925
R01 · FY2008 · NS · contact PI
Calpain inhibitors in models of Parkinson's disease$285,925
R01 · FY2007 · NS · contact PI
Regulation of AMPA Receptors by Ampakines$269,920
P01 · FY2007 · NS · contact PI
Calpain inhibitors in models of Parkinson's disease$317,045
R01 · FY2006 · NS · contact PI
Regulation of AMPA Receptors by Ampakines$221,102
P01 · FY2006 · NS · contact PI
ESTROGEN AND GLUTAMATE RECEPTORS IN PLASTICITY AND AD$114,723
P01 · FY2006 · AG · contact PI
Calpain inhibitors in models of Parkinson's disease$300,625
R01 · FY2005 · NS
Regulation of AMPA Receptors by Ampakines$214,432
P01 · FY2005 · NS
Calpain inhibitors in models of Parkinson's disease$323,750
R01 · FY2004 · NS
Regulation of AMPA Receptors by Ampakines$203,793
P01 · FY2004 · NS
Regulation of AMPA Receptors by Ampakines$236,320
P01 · FY2003 · NS
SOD/Catalase mimics for age-related learning impairment$256,638
R41 · FY2001 · AG
ESTROGEN, GLUTAMATE RECEPTOR IN PLASTICITY AND ALZHEIMER'S DISEASE$137,803
P01 · FY2001 · AG
ESTROGEN, GLUTAMATE RECEPTOR IN PLASTICITY AND ALZHEIMER'S DISEASE$0
P01 · FY2001 · AG
ESTROGEN, GLUTAMATE RECEPTOR IN PLASTICITY AND ALZHEIMER'S DISEASE$157,152
P01 · FY2000 · AG